SomnoMed Limited
SomnoMed Limited, together with its subsidiaries, produce and sells devices for the oral treatment of sleep related disorders in the Asia Pacific region, North America, and Europe. It provides SomnoDent Avant, as well as SomnoDent Classic, SomnoDent Flex, and SomnoDent Fusion are offered for the treatment of obstructive sleep apnea. The company also offers SomMorning Repositioner, a product desig… Read more
SomnoMed Limited (SOMNF) - Total Assets
Latest total assets as of June 2025: $80.97 Million USD
Based on the latest financial reports, SomnoMed Limited (SOMNF) holds total assets worth $80.97 Million USD as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
SomnoMed Limited - Total Assets Trend (2004–2025)
This chart illustrates how SomnoMed Limited’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
SomnoMed Limited - Asset Composition Analysis
Current Asset Composition (June 2025)
SomnoMed Limited's total assets of $80.97 Million consist of 53.3% current assets and 46.7% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 21.4% |
| Accounts Receivable | $11.19 Million | 13.8% |
| Inventory | $7.43 Million | 9.2% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $1.56 Million | 1.9% |
| Goodwill | $7.05 Million | 8.7% |
Asset Composition Trend (2004–2025)
This chart illustrates how SomnoMed Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: SomnoMed Limited's current assets represent 53.3% of total assets in 2025, an increase from 12.5% in 2004.
- Cash Position: Cash and equivalents constituted 21.4% of total assets in 2025, up from 8.2% in 2004.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 9.0% of total assets, a decrease from 83.0% in 2004.
- Asset Diversification: The largest asset category is accounts receivable at 13.8% of total assets.
SomnoMed Limited Competitors by Total Assets
Key competitors of SomnoMed Limited based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
SomnoMed Limited - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - SomnoMed Limited generates 1.38x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - SomnoMed Limited is currently not profitable relative to its asset base.
SomnoMed Limited - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.51 | 1.76 | 2.14 |
| Quick Ratio | 1.25 | 1.45 | 2.02 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $14.56 Million | $ 15.20 Million | $ 21.45 Million |
SomnoMed Limited - Advanced Valuation Insights
This section examines the relationship between SomnoMed Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.40 |
| Latest Market Cap to Assets Ratio | 0.54 |
| Asset Growth Rate (YoY) | 16.0% |
| Total Assets | $80.97 Million |
| Market Capitalization | $43.88 Million USD |
Valuation Analysis
Below Book Valuation: The market values SomnoMed Limited's assets below their book value (0.54 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: SomnoMed Limited's assets grew by 16.0% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for SomnoMed Limited (2004–2025)
The table below shows the annual total assets of SomnoMed Limited from 2004 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-06-30 | $80.97 Million | +16.00% |
| 2024-06-30 | $69.80 Million | +11.70% |
| 2023-06-30 | $62.49 Million | +7.57% |
| 2022-06-30 | $58.09 Million | +3.43% |
| 2021-06-30 | $56.17 Million | -8.96% |
| 2020-06-30 | $61.69 Million | +77.53% |
| 2019-06-30 | $34.75 Million | -23.95% |
| 2018-06-30 | $45.70 Million | +10.88% |
| 2017-06-30 | $41.21 Million | +1.94% |
| 2016-06-30 | $40.43 Million | +45.68% |
| 2015-06-30 | $27.75 Million | +44.97% |
| 2014-06-30 | $19.14 Million | +4.59% |
| 2013-06-30 | $18.30 Million | +48.66% |
| 2012-06-30 | $12.31 Million | +40.99% |
| 2011-06-30 | $8.73 Million | +11.46% |
| 2010-06-30 | $7.83 Million | +29.74% |
| 2009-06-30 | $6.04 Million | -13.80% |
| 2008-06-30 | $7.00 Million | +49.07% |
| 2007-06-30 | $4.70 Million | +15.47% |
| 2006-06-30 | $4.07 Million | -48.61% |
| 2005-06-30 | $7.92 Million | +1167.43% |
| 2004-06-30 | $624.71K | -- |